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Background: The risk of peri-procedural myocardial infarction (MI) during percutane-
ous coronary intervention (PCI) of chronic total occlusions (CTOs) is reported to be low,
however it may be underestimated because systematic cardiac biomarker measurement
was not performed in prior studies.
Methods: We retrospectively examined the incidence of peri-procedural MI among 325
consecutive CTO PCIs performed at our institution between 2006 and 2012. Creatine
kinase MB fraction (CK-MB) and troponin T or I was measured before PCI and after 8-12
and 18-24 hours in all patients. Myocardial infarction was defined as CK-MB increase
3x upper limit of normal.
Results: Mean age was 6410 years, 99 % or patients were men, 47% had diabetes, 26
% had prior coronary artery bypass graft surgery and 47% had prior PCI. The CTO target
vessel was the right coronary artery (56%), left anterior descending artery (21.5%),
circumflex (20.5%), and left main or bypass graft (1%). The retrograde approach was used
in 26.3% of all procedures. The technical and procedural success rates were 77.2% and
76%, respectively. The mean procedural time, fluoroscopy time, radiation dose and
contrast utilization was 14172 minutes, 4022 minutes, 4.62.4 Gray and 356146
ml, respectively. Peri-procedural MI occurred in 28 of 325 patients (8.6%). Seven of those
patients had ischemic symptoms. The prevalence of peri-procedural cardiac troponin
elevation 3x, 10x, and 20x upper limit of normal was 57%, 24% and 7.6%,
respectively. The incidence of peri-procedural MI was similar among patients with
procedural failure vs. procedural success (11.8% vs. 7.6%, p0.26), but was higher with
the retrograde compared to the antegrade approach (13.8% vs. 6.7%, p0.04).
Conclusions: Systematic measurement of cardiac biomarkers post CTO PCI demon-
strates that peri-procedural MI occurs in 8.6% of patients and is more common with the
retrograde approach.
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Background: Percutaneous coronary intervention (PCI) of chronic total occlusions
(CTOs) is a rapidly evolving area of interventional cardiology. We examined the
outcomes of CTO PCI from a multicenter United States registry.
Methods: We retrospectively examined the procedural outcomes of 1363 consecutive
CTO PCIs performed at 3 US institutions [St. Joseph Medical Center, Bellingham
Washington (n728), Piedmont Hospital, Atlanta Georgia (n361) and VA North Texas
Healthcare System, Dallas, Texas (n275)] between January 2006 and November 2011.
Results: Mean age was 6510 years, 85% or patients were men, 40% had diabetes, 37%
had prior coronary artery bypass graft surgery and 42% had prior PCI. The CTO target
vessel was the right coronary artery (55%), circumflex (23%), left anterior descending
artery (21%), and left main or bypass graft (1%). The retrograde approach was used in
34.4% of all procedures. The technical and procedural success rate was 85.5% and 84.2%,
respectively. The mean procedural time, fluoroscopy time and contrast utilization was
11463 minutes, 42 29minutes, and 296160 ml, respectively. A major procedural
complication occurred in 24 patients (1.8%): 3 patients died (1 due to intracranial
bleeding, 1 due to delayed cardiac tamponade, 1 due to coronary perforation), 5 had
Q-wave myocardial infarction, 2 donor vessel dissections (one requiring coronary bypass
graft surgery and one treated with stenting), 2 had equipment entrapment requiring coil
occlusion of a ventricular septal defect and the other requiring emergent surgery, 1 had
acute stent thrombosis, 1 had a transient ischemic attack and 10 patients had perforations
requiring pericardiocentesis or emergent surgery.
Conclusions: Among 3 high-volume US centers, CTO PCI can be performed with high
success and low complication rates, with use of the retrograde approach in approximately
one third of patients.
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Background: Despite increasing application of the radial route for PCI, recanalization of
chronic total occlusion has remained largely a trans-femoral procedure, to allow use of
larger catheters and achieve powerful support. We adopted the radial approach as routine
for all PCIs including CTOs starting 2007 and observed satisfactory treatment of CTOs.
In this study, we sought to compare procedural outcomes of radial versus femoral
approach to CTO reopening.
Methods: This is a single center observational study of consecutive patients who had
CTO recanalization or attempted reopening. Study patients were identified from a
prospectively maintained interventional database.Clinical background, procedure detail
and outcome were reviewed and analyzed.
Results: 162(93 radial, 69 femoral) consecutive patients had recanalization or attempted
recanalization of CTO. Mean age is 65.5 years and males constitute 84.4%. There were
no significant differences in baseline characteristics or in target artery between the two
groups. All occlusions were  6months and up to 12 years. Bilateral radial access was
used in 31.2%; unilateral radial in 66.7% and 2 cases had radial	 femoral 5F diagnostic
for contra-lateral injection. RCA was target artery in 53.0 % and 97.2 % had multi-vessel
disease. Overall success rate was 74.7% and trans-radial vs. trans-femoral was 83.9 vs.
62.3 % (P-value 0.01). The mean fluoroscopy time was 24.9 minutes and was similar for
both groups. No significant difference in contrast use and radiation dose was observed.
Access site complications were higher among trans-femoral group. One pseudo-aneurysm
and 2 major bleedings were encountered in the femoral group where as systemic and
coronary complications are similar for both group.
Conclusions: Radial approach for CTO re-canalisation did not hamper success and
actually was associated with higher success rates than femoral approach, probably thanks
to improved guide-wire and supporting micro-catheter technology during the last 5 years
covered. Lower complication rates, with similar radiation exposure and contrast use
encourage us to persist with the radial access including bilateral radial approach to CTOs
as the default strategy than double femoral
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Background: We previously reported promising outcomes after treatment of coronary
bifurcation lesions with the Tryton Side Branch Stent™ in more than 900 patients.
Surprisingly, acute coronary syndrome (ACS) as percutaneous coronary intervention
(PCI) indication did not predict for adverse outcomes compared to patients without ACS.
Therefore, we evaluated the differences in clinical outcomes between patients presenting
with stable/unstable angina, NSTEMI and STEMI.
Methods: Patients with stable/unstable angina, NSTEMI or STEMI as PCI indication
were included. One-year clinical outcomes were stratified according to indication and
reported as the composite of cardiac death and myocardial infarction (MI), clinically
indicated target vessel revascularization (TVR), definite/probable stent thrombosis (ST)
and target vessel failure (TVF; composite of any death, MI, and clinically indicated TVR).
Procedural success was defined as successful stent placement and no in-hospital TVF.
Results: We included 786 patients (79% stable/unstable angina, 14% NSTEMI, 7%
STEMI). In patients treated for STEMI, death/MI, clinically indicated TVR, and TVF
rates were higher than in patients without STEMI. However, these differences were not
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statistically significant (see figure). Three STs were observed, all in the stable/unstable
angina group. Procedural success was 96% in all groups.
Conclusions: Clinical outcomes were not different among patients treated with the
Tryton stent presenting with stable/unstable angina, NSTEMI and STEMI. The use of the
Tryton stent seems to be safe and feasible in patients presenting with MI, including
STEMI.
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Background: Previous studies have suggested safety and efficacy of DES in patients
with AMI compared to bare metal stents. However, the very long-term follow-up of
patients with AMI treated with DES in the real-world clinical practice remains unknown.
Our objective was to investigate the late outcomes of patients with recent acute
myocardial infarction (MI) treated with drug-eluting stents (DES) in daily clinical
practice.
Methods: The DESIRE (Drug-Eluting Stent in the Real World) Registry is a prospective,
non-randomized clinical trial evaluating the long-term clinical FU of pts undergoing
elective or urgent percutaneous coronary intervention (PCI) with DES as the default
strategy in a single center. From 05/02 to 05/12, 4,229 pts (6,518 lesions) were treated
with 7,000 DES. Clinical FU was performed at 1, 6 and 12 months, and annually up to
10 years (FU in 97%, median 4.9 years). Patients were divided into 2 groups according
to their clinical presentation: Group 1 - patients with recent MI (30 days), n656;
Group 2 - patients without recent MI, n3,573, and results were compared.
Results: Group 1 had less co-morbidities, but more multivessel disease (71 vs. 62%,
p0.0002), thrombus containing lesions (12 vs. 1.4%, p0.001), TIMI flow 0/1 (8 vs.
1.2%, p0.001), and moderate/severe left ventricular dysfunction (20 vs. 8%, p0.001)
compared to Group 2. Overall, there were 1.60.8 stents/patient; Group 1 received more
glycoprotein IIb/IIIa inhibitors (13 vs. 2%, p0.001), but angiographic success was
similar in both groups (99%). Clinical outcomes are shown in the Table
Cumulative Events Group 1 Group 2 p value
Cardiac death 6.7% 3.6% 0.0003
MI 6.5% 7.1% 0.63
TLR 3% 5.1% 0.04
Stent thrombosis (ARC) 4.5% 2.0% 0.0001
- Early (30 days) 1.1% 0.2% 0.0004
- Late (1-12 months) 1.4% 0.5% 0.007
- Very late (12 months) 2.0% 1.3% 0.15
Conclusions: Patients with primary clinical presentation of recent MI (30 days)
undergoing DES had worse long-term prognosis compared to those without recent MI,
including increased rates of cardiac death (p0.0003) and stent thrombosis (P0.0001)
up to 10 years FU.
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Background: The clinical outcome of patients presenting coronary artery ectasia and
acute myocardial infarction is poorly defined. The aim of this study was to analyze the
mid-long term clinical outcome of patients treated by primary angioplasty in whom the
culprit lesion was localized in an ectatic vessel.
Methods: A systematic review of the databases of eight Italian centers identified 101
patients with coronary artery ectasia who were treated by primary percutaneous coronary
intervention (PCI). The end points of the study were the incidence of cardiac death, need
of any new revascularization, recurrence of acute myocardial infarction and the combined
end point of cardiac death and/or recurrence of acute myocardial infarction during a
follow-up mean time of 15.4 months. Cumulative cardiac mortality was evaluated with
Kaplan-Meier method. Cox proportional hazard model was used to calculate hazard ratios
(HR) and 95% confidence intervals (95% CI) for selected potential predictors of cardiac
mortality.
Results: The right coronary artery was the principal ectatic vessel involved in acute
myocardial infarction (54%), particularly in Type 3 ectasia (p0.001). Cardiac mortality
rate was 5.9% (95% CI: 1.3-10.5) in hospital, 7.1% (95% CI: 3.4-14.3) at 1 year, and
12.8% (95% CI: 6.2-25.7) at 2 years. The most important factors related with cardiac
death and survival were: male gender, TIMI 3, single lesion PCI and successful PCI
(reduced mortality), age  63.5 years, Killip class  1, and complicated PCI (increased
mortality).
Cox proportional-hazards model of cardiac death
Variables No. Deaths HR 95% CI p-value
Gender
Male 8 0.17 0.03–0.87 0.03
Mean age (years)
 63.5 8 4.54 0.96–21.40 0.056
Killip classification
Killip class  1 6 6.51 1.80–23.56 0.004
PCI characteristics
Single lesion PCI 6 0.25 0.07–0.96 0.04
TIMI
 3 4 0.27 0.08–0.98 0.047
PCI results
Successful 5 0.19 0.05–0.67 0.01
With
complications
3 4.75 1.18–19.10 0.03
Conclusions: Based on our observations, the clinical outcome at mid-long term of
patients with coronary artery ectasia treated by primary angioplasty in the setting of acute
myocardial infarction seems to be in line with that reported in the Italian epidemiological
registries for acute coronary syndromes. No association between different types of ectasia
and major adverse cardiac events was found.
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Background: It is not still unclear which procedure is superior between TRI and TFI in
terms of in-hospital morbidities and outcomes in acute myocardial infarction patients.
Methods: Using KORMI (Korean registry of myocardial infarction) data (from 2008
January to 2011 Aug), in-hospital morbidities and cumulative clinical outcomes of TRI
group were compared to those of TFI group in STEMI and NSTEMI patients. Data of
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